Atropine Sulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Accord Healthcare Inc. with status Current. The shortage was first posted on 01/01/2020. Reported reason: Discontinuation of the manufacture of the drug
Shortage Details
- Status
- Current
- Company
- Accord Healthcare Inc.
- Package NDC
- 16729-484-90
- Dosage Form
- Injection
- Presentation
- Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)
- Initial Posting
- 01/01/2020
- Revised Date
Reason
Discontinuation of the manufacture of the drug